There is a globally inequitable distribution of medical imaging, and high-cost modalities for NF1 surveillance such as MRI and FDG PET/CT have many barriers to access in low- and middle-income economies [78], making their widespread employment in adult NF1 surveillance implausible. Here, NF1 is linked to neurofibromatosis type 1.